Drug Patent Expirations for Mar 10, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. METVIXIA (methyl aminolevulinate hydrochloride) Galderma Labs Lp Patent number: 6,034,267 Expiration Date: Mar 8, 2016 SUMAVEL DOSEPRO (sumatriptan succinate) Endo Ventures Ltd Patent number: 5,957,886 Expiration […]


Drug Patent Expirations for Mar 3, 2016

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. LUXIQ (betamethasone valerate) Delcor Asset Patent number: 6,126,920 Expiration Date: Mar 1, 2016 FAMVIR (famciclovir) Novartis Patent number: 5,916,893 Expiration Date: Mar 1, 2016 ZELAPAR (selegiline hydrochloride) Valeant […]


Drug Patent Expirations in February 2016

Drug Patent Expirations for February 2016

Tradename
Applicant
Generic Name
Patent Number
Patent Expiration
ELOXATIN
Sanofi Aventis Us
oxaliplatin
5,716,988*PED
Feb 7, 2016

JUXTAPID
Aegerion
lomitapide mesylate
5,712,279
Feb 21, 2016

ARNUITY ELLIPTA…


Legal and regulatory update

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Legal and regulatory update
Go to paperABSTRACT: The Office of Fair Trading (OFT) has recently found Genzyme Limited guilty of abusing its dominant posi…


Drug Patent Expirations for Feb 4, 2016

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. ELOXATIN (oxaliplatin) Sanofi Aventis Us Patent number: 5,716,988 Expiration Date: Feb 7, 2016 For more information try a free trial


Drug Patent Expirations for Jan 28, 2016

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. NUEDEXTA (dextromethorphan hydrobromide; quinidine sulfate) Avanir Pharms Patent number: RE 38,115 Expiration Date: Jan 26, 2016 UTIBRON (glycopyrrolate ; indacaterol maleate) Novartis Pharms Corp Patent number: 6,521,260 Expiration […]


Make in India — nowhere to go but up

Make in India recently published an advertorial in the Washington Post proclaiming that “2016 is India’s Growth Year For Pharma.” I don’t doubt that India has growth potential, as it ranks 51st out of 54 nations that I compare in the Scientific American Worldview scorecard. The problem with Make in India’s encouraging proclamation is that […]


Understanding 'science and the public'

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Understanding ‘science and the public’
Go to paperABSTRACT: Public acceptance of the products of biotechnology is an important issue for the industry. T…


Festo: The plague continues

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Festo: The plague continues
Go to paperABSTRACT: This paper reviews the law on the doctrine of equivalence and prosecution history estoppel and explores…


Do NOT follow this link or you will be banned from the site!